Verification evidence is still being completed.
PDF / print export
ALK-Abelló
Horsholm, Denmark
- Verified lead
- Peter Halling
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President and Chief Executive Officer
- 2026 technical specialization
- Allergy Vaccines, Immunotherapy Manufacturing, and Regulated Product Supply
- Review cycle
- May 2026
- Full address
- Bøge Allé 6-8, DK-2970 Hørsholm, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official ALK executive leadership page confirming Peter Halling as President and CEO.
- Editorial note
- Allergy-immunotherapy manufacturing anchor with standardized vaccine production, regulated supply continuity, and commercial product-release discipline.
Allergy Vaccines, Immunotherapy Manufacturing, and Regulated Product Supply
GMP allergy-vaccine manufacturing, Commercial quality systems
Allergy-immunotherapy manufacturing anchor with standardized vaccine production, regulated supply continuity, and commercial product-release discipline.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Horsholm, Denmark
ALK-Abelló
Allergy Vaccines, Immunotherapy Manufacturing, and Regulated Product Supply · Commercial specialty manufacturing
Allergy-immunotherapy manufacturing anchor with standardized vaccine production, regulated supply continuity, and commercial product-release discipline.
- Lead
- Peter Halling (verified ↗)
- Address
- Bøge Allé 6-8, DK-2970 Hørsholm, Denmark (source ↗)
- Compliance
- GMP allergy-vaccine manufacturing
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Commercial specialty manufacturing
- Capabilities
- Allergy Immunotherapy · Tablet and Vaccine Production · Commercial Product Supply
- Founded
- 1923
- Headcount
- 1001-5000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Peter Halling
President and Chief Executive Officer
Full addressBøge Allé 6-8, DK-2970 Hørsholm, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official ALK contact page naming ALK-Abelló A/S at Bøge Allé 6-8 in Hørsholm.
Open sourceCommercial specialty manufacturing
Horsholm, Denmark. Allergy Vaccines, Immunotherapy Manufacturing, and Regulated Product Supply. Review completed on 14 Mar 2026.
Danish Medicines Agency and global allergy-immunotherapy oversight
GMP allergy-vaccine manufacturing, Commercial quality systems
Allergy Vaccines, Immunotherapy Manufacturing, and Regulated Product Supply
Allergy-immunotherapy manufacturing anchor with standardized vaccine production, regulated supply continuity, and commercial product-release discipline.
Editorial note
ALK extends the Danish layer with a source-backed executive record and a clear production narrative tied to allergy-vaccine manufacturing.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Allergy Immunotherapy
Tablet and Vaccine Production
Commercial Product Supply
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Production suites
Quality-control laboratories
Commercial supply systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is ALK-Abelló located?
- ALK-Abelló operates from Bøge Allé 6-8, DK-2970 Hørsholm, Denmark, Horsholm, Denmark.
- Who runs ALK-Abelló?
- ALK-Abelló is led by Peter Halling, President and Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does ALK-Abelló hold?
- ALK-Abelló is documented under GMP allergy-vaccine manufacturing.
- What does ALK-Abelló do?
- Allergy-immunotherapy manufacturing anchor with standardized vaccine production, regulated supply continuity, and commercial product-release discipline. Core capabilities: Allergy Immunotherapy, Tablet and Vaccine Production, Commercial Product Supply.
Editorial context
Related technical briefs
Briefs that name Horsholm as a covered market or city.